Filings

2 documents · 15 matches

1. CGON CG Oncology, Inc. 10-K 2026-02-27

   Item 1A. Risk Factors.

   tariffs will result in increased research and development expenses, including with respect to increased costs associated with APIs, raw materials
   9 matches in this document Show context Copy citation

2. CGON CG Oncology, Inc. 10-Q 2025-08-08

   Item 1A. Risk Factors.

   tariffs will result in increased research and development expenses, including with respect to increased costs associated with APIs, raw materials
   6 matches in this document Show context Copy citation